AstraZeneca (AZN) declines to comment on M&A speculation - Bloomberg, citing spokesperson
- Wall Street opens flat as investors assess earnings
- General Motors (GM) Tops Q3 EPS by 28c
- Procter & Gamble (PG) Tops Q1 EPS by 5c
- DuPont (DD) Tops Q3 EPS by 14c; Boosts FY16 EPS Outlook; Says Continuing to Work with Regulators
- Pre-Open Stock Movers 10/25: (SAEX) (CWEI) (SWFT) Higher; (DPRX) (CRBP) (UA) Lower (more...)
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
AstraZeneca (NYSE: AZN) declines to comment on M&A speculation - Bloomberg, citing spokesperson
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Allergan to Present New Data from its Anti-Infectives Portfolio at IDWeek 2016 in New Orleans
- Energy Transfer Partners (ETP) to Acquire PennTex Development (PTXP)
- Stocks with Implied Volatility Movement
Create E-mail Alert Related CategoriesMergers and Acquisitions, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!